NDAORALTABLET
Approved
Feb 2013
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Mechanism of Action
Selective Estrogen Receptor Modulators
Pharmacologic Class:
Estrogen Agonist/Antagonist
Loss of Exclusivity
LOE Date
Jul 9, 2028
28 months away
Patent Expiry
Jul 9, 2028